跳至主要内容
临床试验/KCT0003766
KCT0003766已完成未知

Evaluation of OFE on the Mild Cognitive Impairment for the Efficacy and Safety: A 12 week, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial

Koreaeundan0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
55(Year) 至 85(Year)(—)
性别
All

入选标准

  • With subjective memory complaints
  • With Literacy
  • Who have scores in memroy domains of CERAD-K below -1.0 SD
  • Who agree informed consent

排除标准

  • Inpatient or within 3 months after discharge with malignancy, severe cerebrovascular diseasd, severe cardiac disease
  • Schizophrenia, major depressive disorder
  • Dementia, Parkinson disease, cerebral infarction
  • The patient who taking the cerebral enhancer test before 4 weeks
  • The patient who taking more than 400IU of vitamin E
  • Alcohol abuse or dependence
  • Thyroid disease
  • Renal or hepatic dysfunction
  • Uncontrolled high blood glucose and high blood preasure
  • Pregnancy or breast feeding
  • The patient who involved with 3 months with other human clinical trial
  • The patient who is not suitable for this clinical trial by investigator

研究者

发起方
Koreaeundan

相似试验

Effect of OFE on the Mild Cognitive Impairment | 临床试验